“…Importantly, methamphetamine decreased time spent in N3 and REM sleep even at doses that did not significantly decrease total sleep time. Of note, the overall effects of methamphetamine reported in this study are consistent with those previously reported under similar conditions, but using actigraphy-based sleep, in our laboratory ( Berro et al, 2021a ). In both studies, only the dose of 0.3 mg/kg of methamphetamine significantly increased sleep latency and decreased sleep efficiency (which can be inferred from the present study by the equation: total sleep time/12 h*100).…”
Section: Discussionsupporting
confidence: 91%
“…In both studies, only the dose of 0.3 mg/kg of methamphetamine significantly increased sleep latency and decreased sleep efficiency (which can be inferred from the present study by the equation: total sleep time/12 h*100). Our actigraphy-based sleep study showed a ∼700 ± 412% increase in sleep latency and a ∼24 ± 4% decrease in sleep efficiency following 0.3 mg/kg methamphetamine administration compared to baseline ( Berro et al, 2021a ), and our current data show a 150 ± 83% increase in sleep latency and a 30 ± 7% decrease in sleep efficiency compared to baseline. Different subjects were used in the two studies, which could explain some of the variability between the two data sets.…”
Section: Discussionsupporting
confidence: 62%
“… Herrmann et al (2017) showed that morning administration of oral methamphetamine disrupted polysomnography-based sleep parameters in recreational stimulant users, increasing latency to fall asleep and decreasing sleep efficiency. Corroborating these findings, we have shown previously that morning administration of methamphetamine disrupts actigraphy-based sleep parameters in rhesus monkeys, increasing sleep latency and decreasing sleep efficiency both in naïve monkeys ( Berro et al, 2021a ) and in monkeys with a chronic history of methamphetamine intake ( Berro et al, 2016 , 2017a , b ). Importantly, Herrmann et al (2017) also showed that methamphetamine dose-dependently decreased time in sleep stage N2 and in rapid eye movement (REM) sleep, as well as the number of REM sleep episodes.…”
Section: Introductionsupporting
confidence: 64%
“…While it is well known from the human literature that aging can influence sleep duration, particularly REM sleep duration ( Roffwarg et al, 1966 ), at least up until 15 years of age we do not see significant changes in sleep architecture with rhesus monkeys (results from the present study), and up to 20 years old, no age-related changes in actigraphy-based sleep have been reported ( Berro et al, 2021b ). We have previously reported that one 25 year old monkey in our colony showed longer baseline sleep latency and shorter baseline sleep duration compared to other monkeys (subject 98-003, Berro et al, 2021a ). However, other monkeys in our colony, as young as 9 years old, also show shorter sleep duration ( Berro et al, 2021a , 2022 ), demonstrating that, like humans, the sleep patterns of non-human primates may vary greatly between individual subjects.…”
Section: Discussionmentioning
confidence: 69%
“…We have previously reported that one 25 year old monkey in our colony showed longer baseline sleep latency and shorter baseline sleep duration compared to other monkeys (subject 98-003, Berro et al, 2021a ). However, other monkeys in our colony, as young as 9 years old, also show shorter sleep duration ( Berro et al, 2021a , 2022 ), demonstrating that, like humans, the sleep patterns of non-human primates may vary greatly between individual subjects.…”
Use of amphetamine-type stimulants is associated with numerous adverse health outcomes, with disturbed sleep being one of the most prominent consequences of methamphetamine use. However, the extent to which methamphetamine alters sleep architecture, and whether methamphetamine-induced sleep impairment is associated with next-day sleep rebound effects, has received relatively little investigation. In the present study, we investigated the effects of acute morning methamphetamine administration on sleep parameters in adult male rhesus monkeys (N = 4) using a fully-implantable telemetry system. Monkeys were prepared with telemetry devices that continuously monitored electroencephalography (EEG), electromyography (EMG) and electrooculography (EOG) throughout the night. We investigated the effects of morning (10h00) administration of methamphetamine (0.01–0.3 mg/kg, i.m.) on sleep during the night of the injection. In addition, we investigated sleep during the subsequent night in order to assess the possible emergence of sleep rebound effects. Methamphetamine administration dose-dependently increased sleep latency and wake time after sleep onset (WASO). Methamphetamine also decreased total sleep time, which was reflected by a decrease in total time spent in N2, slow-wave (N3) and REM sleep stages, while increasing the percentage of total sleep time spent in sleep stage N1. Importantly, methamphetamine decreased time spent in N3 and REM sleep even at doses that did not significantly decrease total sleep time. Sleep rebound effects were observed on the second night after methamphetamine administration, with increased total sleep time reflected by a selective increase in time spent in sleep stages N3 and REM, as well as a decrease in REM sleep latency. Our findings show that methamphetamine administered 8 h prior to the inactive (dark) phase induces marked changes in sleep architecture in rhesus monkeys, even at doses that do not change sleep duration, and that sleep rebound effects are observed the following day for both N3 and REM sleep stages.
“…Importantly, methamphetamine decreased time spent in N3 and REM sleep even at doses that did not significantly decrease total sleep time. Of note, the overall effects of methamphetamine reported in this study are consistent with those previously reported under similar conditions, but using actigraphy-based sleep, in our laboratory ( Berro et al, 2021a ). In both studies, only the dose of 0.3 mg/kg of methamphetamine significantly increased sleep latency and decreased sleep efficiency (which can be inferred from the present study by the equation: total sleep time/12 h*100).…”
Section: Discussionsupporting
confidence: 91%
“…In both studies, only the dose of 0.3 mg/kg of methamphetamine significantly increased sleep latency and decreased sleep efficiency (which can be inferred from the present study by the equation: total sleep time/12 h*100). Our actigraphy-based sleep study showed a ∼700 ± 412% increase in sleep latency and a ∼24 ± 4% decrease in sleep efficiency following 0.3 mg/kg methamphetamine administration compared to baseline ( Berro et al, 2021a ), and our current data show a 150 ± 83% increase in sleep latency and a 30 ± 7% decrease in sleep efficiency compared to baseline. Different subjects were used in the two studies, which could explain some of the variability between the two data sets.…”
Section: Discussionsupporting
confidence: 62%
“… Herrmann et al (2017) showed that morning administration of oral methamphetamine disrupted polysomnography-based sleep parameters in recreational stimulant users, increasing latency to fall asleep and decreasing sleep efficiency. Corroborating these findings, we have shown previously that morning administration of methamphetamine disrupts actigraphy-based sleep parameters in rhesus monkeys, increasing sleep latency and decreasing sleep efficiency both in naïve monkeys ( Berro et al, 2021a ) and in monkeys with a chronic history of methamphetamine intake ( Berro et al, 2016 , 2017a , b ). Importantly, Herrmann et al (2017) also showed that methamphetamine dose-dependently decreased time in sleep stage N2 and in rapid eye movement (REM) sleep, as well as the number of REM sleep episodes.…”
Section: Introductionsupporting
confidence: 64%
“…While it is well known from the human literature that aging can influence sleep duration, particularly REM sleep duration ( Roffwarg et al, 1966 ), at least up until 15 years of age we do not see significant changes in sleep architecture with rhesus monkeys (results from the present study), and up to 20 years old, no age-related changes in actigraphy-based sleep have been reported ( Berro et al, 2021b ). We have previously reported that one 25 year old monkey in our colony showed longer baseline sleep latency and shorter baseline sleep duration compared to other monkeys (subject 98-003, Berro et al, 2021a ). However, other monkeys in our colony, as young as 9 years old, also show shorter sleep duration ( Berro et al, 2021a , 2022 ), demonstrating that, like humans, the sleep patterns of non-human primates may vary greatly between individual subjects.…”
Section: Discussionmentioning
confidence: 69%
“…We have previously reported that one 25 year old monkey in our colony showed longer baseline sleep latency and shorter baseline sleep duration compared to other monkeys (subject 98-003, Berro et al, 2021a ). However, other monkeys in our colony, as young as 9 years old, also show shorter sleep duration ( Berro et al, 2021a , 2022 ), demonstrating that, like humans, the sleep patterns of non-human primates may vary greatly between individual subjects.…”
Use of amphetamine-type stimulants is associated with numerous adverse health outcomes, with disturbed sleep being one of the most prominent consequences of methamphetamine use. However, the extent to which methamphetamine alters sleep architecture, and whether methamphetamine-induced sleep impairment is associated with next-day sleep rebound effects, has received relatively little investigation. In the present study, we investigated the effects of acute morning methamphetamine administration on sleep parameters in adult male rhesus monkeys (N = 4) using a fully-implantable telemetry system. Monkeys were prepared with telemetry devices that continuously monitored electroencephalography (EEG), electromyography (EMG) and electrooculography (EOG) throughout the night. We investigated the effects of morning (10h00) administration of methamphetamine (0.01–0.3 mg/kg, i.m.) on sleep during the night of the injection. In addition, we investigated sleep during the subsequent night in order to assess the possible emergence of sleep rebound effects. Methamphetamine administration dose-dependently increased sleep latency and wake time after sleep onset (WASO). Methamphetamine also decreased total sleep time, which was reflected by a decrease in total time spent in N2, slow-wave (N3) and REM sleep stages, while increasing the percentage of total sleep time spent in sleep stage N1. Importantly, methamphetamine decreased time spent in N3 and REM sleep even at doses that did not significantly decrease total sleep time. Sleep rebound effects were observed on the second night after methamphetamine administration, with increased total sleep time reflected by a selective increase in time spent in sleep stages N3 and REM, as well as a decrease in REM sleep latency. Our findings show that methamphetamine administered 8 h prior to the inactive (dark) phase induces marked changes in sleep architecture in rhesus monkeys, even at doses that do not change sleep duration, and that sleep rebound effects are observed the following day for both N3 and REM sleep stages.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.